Skip to search formSkip to main contentSkip to account menu

cetuximab/irinotecan

Known as: CPT-11/MOAB C225 
National Institutes of Health

Related topics

Related topics

2 relations
Irinotecan hydrochloridecetuximab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Abstract 3641: Breaking through the ceiling: A program to significantly increase efficacy in KRAS and BRAF mutant colorectal cancer xenograft tumors whose growth is arrested by Cetuximab + irinotecan…
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Cetuximab has significant clinical benefits alone or in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)